Incidence of hypercalcemia and thiazide associated hypercalcemia on an OPD basis biochemical evaluation
Author(s) -
Moomin Hussain Bhat,
Mosin Saleem Khan,
Shariq Rashid Masoodi,
Shuja Abass,
Javaid Rasool Bhat,
Peerzada Ovais Ahmad,
Bisma Rafiq Wangnoo,
Taief Ahmad Dar,
Bathsheeba Andrabi,
Syed Mudassar
Publication year - 2019
Publication title -
j med sci
Language(s) - English
Resource type - Journals
eISSN - 2582-063X
pISSN - 0972-110X
DOI - 10.33883/jms.v22i1.436
Subject(s) - thiazide , medicine , incidence (geometry) , primary hyperparathyroidism , concomitant , prospective cohort study , outpatient clinic , hypokalemia , gastroenterology , diuretic , physics , optics
Background: Hypercalcemia is most of the times diagnosed on routine biochemical evaluation, and concomitant use of thiazide diuretics is common since this group of antihypertensives is frequently prescribed worldwide.
Objective: To determine the incidence of hypercalcemia as well as thiazide-induced hypercalcemia on an OPD basis
Methods: In a prospective hospital-based descriptive study, patients for routine evaluation, attending outpatient clinics.
Results: A total of 373 patients participated in the study, out of which 101(27.1%) were hypertensive. 30 of the 101 hypertensive patients were on thiazides. Hypercalcemia was present in total of 7 (1.9%) patients, primary hyperparathyroidism was seen in 4 patients, out of which 2 patients were on thiazides. 6.7% (2/30) of the patients on thiazides were having hypercalcemia as compared to 1.5% (5/343) patients, not on thiazides (p=0.044).
Conclusion: About every 50 patients evaluated, one patient has hypercalcemia with frequency of hypercalcemia being significantly higher among subjects receiving thiazides than those not receiving thiazide drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom